Kinetics of guaiacol hydrodeoxygenation (HDO) was studied using supported Mo x C-SBA-15 and as a comparison 5 wt% Pt/C under 30 bar hydrogen at 200°C and 300°C. Catalyst characterization was done by a range of physical methods including also determination of the amount of coke and the nature of adsorbed species. Pt/C gave 2-methoxycyclohexanol as the main product, whereas Mo 2 C-SBA-15 promoted direct deoxygenation exhibiting also strong adsorption of guaiacol on the catalyst surface and formation of oligomers. Thermodynamics of guaiacol HDO was elucidated and the reaction network was proposed based on which kinetic modelling was done.
Transition metal nitrides, carbides and phosphides have the potential to replace the expensive and hazardous catalysts typically used for the conversion of fatty acids. However, there has been little research on the influence of treatment conditions and precursor nature on the properties of such catalytic systems. To better understand these dependencies, we synthesized a number of Mo catalysts by temperature‐programmed reduction (700‐900 °C; CH4/N2, N2/H2) using ammonium heptamolybdate, diammonium phosphate and hexamethylenetetramine (HMT) as Mo, C, N and P sources. The presence of HMT in the precursor mixtures ensured the synthesis of pure phase Mo2C, Mo2N and MoP. Catalytic activity in the (hydro)deoxygenation of stearic acid (240 min; 360 °C; 50 bar of H2) decreased in the following order: Mo2C>Mo2N>MoP. However, all of the studied Mo‐based catalysts showed good deoxygenation efficiency and, thus, represent excellent alternatives to traditional noble and sulfur‐containing catalysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.